Incidence and Management of Diarrhea in Patients With HER2-Positive Breast Cancer Treated With Pertuzumab

In both the metastatic and early-stage breast cancer settings, diarrhea was common but manageable for all pertuzumab-containing regimens. Diarrheal episodes were mainly low grade and occurred most often during the first treatment cycle.

 Ann Oncol

click me